Carnitine palmitoyl transferase 1A (CPT1A) and carnitine transporter CT2 (SLC22A16), rate limiting actors of FAO, are overexpressed in AML and constitute novels targets for a subset of AML [36,37] (for a review, see [18]). The gene discussed is CPT1A; the disease is acute myeloid leukemia.